文献

J-GLOBAL ID：201302222039916417   整理番号：13A0362938

アリスキレンに誘発された顕著な高トリグリセリド血症

Aliskiren Induced Remarkable Hypertriglyceridemia

著者 (10件)： AZUSHIMA Kengo (Dep. of Medical Sci. and Cardiorenal Medicine, Yokohama City Univ. Graduate School of Medicine, JPN) ,  TAMURA Kouichi (Dep. of Medical Sci. and Cardiorenal Medicine, Yokohama City Univ. Graduate School of Medicine, JPN) ,  WAKUI Hiromichi (Dep. of Medical Sci. and Cardiorenal Medicine, Yokohama City Univ. Graduate School of Medicine, JPN) ,  MAEDA Akinobu (Dep. of Medical Sci. and Cardiorenal Medicine, Yokohama City Univ. Graduate School of Medicine, JPN) ,  KANAOKA Tomohiko (Dep. of Medical Sci. and Cardiorenal Medicine, Yokohama City Univ. Graduate School of Medicine, JPN) ,  OHSAWA Masato (Dep. of Medical Sci. and Cardiorenal Medicine, Yokohama City Univ. Graduate School of Medicine, JPN) ,  HAKU Sona (Dep. of Medical Sci. and Cardiorenal Medicine, Yokohama City Univ. Graduate School of Medicine, JPN) ,  UNEDA Kazushi (Dep. of Medical Sci. and Cardiorenal Medicine, Yokohama City Univ. Graduate School of Medicine, JPN) ,  TOYA Yoshiyuki (Dep. of Medical Sci. and Cardiorenal Medicine, Yokohama City Univ. Graduate School of Medicine, JPN) ,  UMEMURA Satoshi (Dep. of Medical Sci. and Cardiorenal Medicine, Yokohama City Univ. Graduate School of Medicine, JPN)
資料名： Internal Medicine (Web)  (Internal Medicine (Web))
巻： 51  号： 24  ページ： 3387-3389 (J-STAGE)  発行年： 2012年 
JST資料番号： U0033A  ISSN： 1349-7235  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： 著者らはここにアリスキレンに誘発された顕著な高トリグリセリド...

シソーラス用語： ヒト ,...
準シソーラス用語： アリスキレン誘発性高トリグリセリド血症 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=13A0362938&from=J-GLOBAL&jstjournalNo=U0033A") }}

分類 (2件)： 中毒の診断  (GD06020B) ,  血管作用薬・降圧薬の臨床への応用  (GW07050U)

物質索引 (1件)： アリスキレン

引用文献 (13件)：

• 1. Staessen JA, Li Y, Richart T, et al. Oral renin inhibitors. Lancet 368: 1449-1456, 2006.
• 2. Parving HH, Persson F, Lewis JB, et al. Aliskiren combined with losartan in type 2 diabetes and nephropathy. N Engl J Med 358: 2433-2446, 2008.
• 3. Schmieder RE, Philipp T, Guerediaga J, et al. Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide. Circulation 119: 417-425, 2009.
• 4. White WB, Bresalier R, Kaplan AP, et al. Safety and tolerability of the direct renin inhibitor aliskiren in combination with angiotensin receptor blockers and thiazide diuretics: a pooled analysis of clinical experience of 12,942 patients. J Clin Hypertens 13: 506-516, 2011.
• 5. Black HR, Weinberger MH, Purkayastha D, et al. Comparative efficacy and safety of combination aliskiren/amlodipine and amlodipine monotherapy in African American with stage 2 hypertension. J Clin Hypertens 13: 571-581, 2011.

タイトルに関連する用語 (3件)： アリスキレン ,  誘発 ,  高トリグリセリド血症